Insider Trading
Track Major Insider Updates On X/Twitter
ALNY Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on ALNY stock insider trading activity, which can give hints on whether Alnylam Pharmaceuticals Inc executives are bullish or bearish on their own company.
Recent insider purchases and sales - ALNY
Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 5445 | Mar 24, 2025 | March 25, 2025, 4:10 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 4321 | Mar 21, 2025 | March 25, 2025, 4:10 p.m. |
PYOTT DAVID E I
|
Sale | 7440 | Mar 24, 2025 | March 25, 2025, 4:09 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 111 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 151 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 121 | Mar 04, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 4 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 45 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 204 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 219 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 224 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 71 | Mar 04, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 465 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 324 | Mar 04, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 487 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 328 | Mar 04, 2025 | March 5, 2025, 5:22 p.m. |
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
|
Sale | 1 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 142 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 96 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 131 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 3 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 29 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Tanguler Tolga
EVP, Chief Commercial Officer
|
Sale | 70 | Mar 03, 2025 | March 5, 2025, 5:22 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 147 | Mar 04, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 343 | Mar 04, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 48 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 116 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 583 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 273 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 117 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 198 | Mar 04, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 213 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 235 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 5 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 1 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 158 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Garg Pushkal
CMO & EVP Dev & Med Affairs
|
Sale | 120 | Mar 04, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 77 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 7 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 382 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 258 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 189 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 350 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Poulton Jeffrey V.
EVP, Chief Financial Officer
|
Sale | 1 | Mar 03, 2025 | March 5, 2025, 5:21 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 4 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 791 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 1173 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 580 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 1068 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |
Greenstreet Yvonne
Chief Executive Officer
|
Sale | 238 | Mar 03, 2025 | March 5, 2025, 5:20 p.m. |